These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14663483)

  • 21. Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities.
    Strudwick S; Borden KL
    Leukemia; 2002 Oct; 16(10):1906-17. PubMed ID: 12357342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
    Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
    J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
    Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
    Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
    Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
    Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
    Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
    Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
    Le XF; Vallian S; Mu ZM; Hung MC; Chang KS
    Oncogene; 1998 Apr; 16(14):1839-49. PubMed ID: 9583681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PML control of cytokine signaling.
    Maarifi G; Chelbi-Alix MK; Nisole S
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):551-61. PubMed ID: 24861946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transcriptional role of PML and the nuclear body.
    Zhong S; Salomoni P; Pandolfi PP
    Nat Cell Biol; 2000 May; 2(5):E85-90. PubMed ID: 10806494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
    Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
    J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.
    Block GJ; Eskiw CH; Dellaire G; Bazett-Jones DP
    Mol Cell Biol; 2006 Dec; 26(23):8814-25. PubMed ID: 16966371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.